Skip to main content
. Author manuscript; available in PMC: 2013 Nov 1.
Published in final edited form as: J Acquir Immune Defic Syndr. 2012 Nov 1;61(3):326–333. doi: 10.1097/QAI.0b013e31826be75e

Figure 1.

Figure 1

Cumulative proportions of patients starting antiretroviral therapy over time for CD4 count thresholds of 500, 350 and 200 cells/μl in simulated data compared with the corresponding estimates (with 95% confidence bands) based on data from the Multicenter AIDS Cohort Study (MACS).